New Options for Rheumatoid Arthritis

Health & Fitness Article Directory, Get Free Reprint Articles and Health & Fitness Content for your site with
article directory
54866 *recent articles in 509 categories Last article added 11/15/07
 
Article Categories
 
Reviews
 
Site Menu
 
Site Search


 
ArticlePros.com » Health & Fitness » Arthritis » New Options for Rheumatoid Arthritis

  • Date: 2007-06-18
  • Author: Mark Ramirez
  • All articles by this author
  • Visit author's website
  • New Options for Rheumatoid Arthritis


    Related Arthritis Articles

         A new era for rheumatoid arthritis is beginning to unfold, leading the charge is several new drugs which are giving arthritis sufferers new options that many have never enjoyed. A new study released Tuesday, three new drugs; rituximab, abatacept and tocilizumab are on the cutting edge of science. Rheumatoid arthritis is a chronic inflammatory joint disease that attacks the joints, producing harsh pain, stiffness and swelling. Rituximab and abatacept have already received approval to treat of patients who suffer from this painful illness. Tocilizumab is still in phase III clinical trials testing. According to HealthDay, Traditional treatments for rheumatoid arthritis include nonsteroidal anti-inflammatory drugs (NSAIDs), glucocorticoids, and disease-modifying anti-rheumatic drugs (DMARDs), which include the widely used Methotrexate. But only DMARDs, and to a certain extent glucocorticoids, can slow or halt rheumatoid arthritis' inflammatory and destructive disease processes, according to background information in the study. Rituxamab targets the CD20 antigen in certain cells, leading to a reduction in the CD20 cell count. Abatacept interferes with T-cell activation response, believed to play an important role in rheumatoid arthritis. Tocilizumab targets interleukin-6, which activates many cell populations. All three forms of treatment have been found to improve signs of arthritis and symptoms, improve patients' physical function and health status, and delay progression of joint damage. All have all been found affective as both stand alone treatments and when used in conjunction with alternate remedies. Although still unapproved, intitial trials of rituximad found that the drug reduced arthritis symptoms by 50 percent for 1/3 of its test group. Visit this Consumer Advocacy website for more information on ordering from a Mexican pharmacies.

    More articles from this pro: http://www.ArticlePros.com/author.php?Mark Ramirez


    More on Health & Fitness and Arthritis can be found here.
     

    Get this article to go

    RSS | JScript | Email | HTML

     

    About the author

    Mark has been in the pharmaceutical search industry since 1999 and has quickly become one of the most widely used pharmaceutical resource sites. Visit this Consumer Advocacy website for more information on ordering from an online <a href="http://www.premiermexicanpharmacies.com">Mexican pharmacy</a>.

    http://www.premiermexicanpharmacies.com

     
    Email options
       

    ** Check all that apply **

     

    This article has been accessed 167 times since 2007-06-18.


    Home  •  Search  •  Add Your Own Article  •  RSS feeds  •  JavaScript Feeds  •   •  Set as Homepage  •  Add to Favourites
    Disclaimer: The information presented and opinions expressed herein are those of the authors
    and do not necessarily represent the views of ArticlePros.com and/or its partners.
    Copyright ArticlePros.com © 2005. All Rights Reserved